Amicus Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

Amicus Therapeutics M&A Summary

Amicus Therapeutics has acquired 2 companies.

Amicus Therapeutics’ largest acquisition to date was in 2015, when it acquired Scioderm for $229M. Amicus Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

Amicus Therapeutics Business Overview

Where is Amicus Therapeutics headquartered?

Amicus Therapeutics is headquartered in Princeton, New Jersey.

What is Amicus Therapeutics’ revenue?

Amicus Therapeutics disclosed revenue of 399M USD for 2023 and 329M USD for 2022.

How many employees does Amicus Therapeutics have?

Amicus Therapeutics has 517 employees.

What sector is Amicus Therapeutics in?

Amicus Therapeutics is a life science company.

When was Amicus Therapeutics founded?

Amicus Therapeutics was founded in 2002.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 2

Amicus Therapeutics

Amicus Therapeutics, Inc.

47 Hulfish Street,
Princeton, New Jersey 08542
United States,
(609) 662-2000
www.amicusrx.com

Amicus Therapeutics is a biotechnology company at the forefront of therapies for rare and orphan diseases. Amicus Therapeutics was founded in 2002 and is based in Princeton, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $404M $404M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Celenex 2018-09-20 175M USD Add-on Acquisition
Columbus, Ohio
Scioderm, Inc. 2015-09-30 229M USD Add-on Acquisition
Raleigh, North Carolina · www.sderm.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 404M (100%) - -
Total 2 $404M - -

By Geo

State/Country Buy Value Sell Value
United States 2 404M - -
  Ohio 1 175M - -
  North Carolina 1 229M - -
Total 2 $404M - -

Top M&A Advisors

Financial Deals
Leerink Partners
1
Legal Deals
Skadden, Arps, Slate, Meagher & Flom
2

Deal Values

buy # Total
$100M to $1B 2 $404M
TOTAL $404M
Largest Scioderm, Inc.
$229M (2015-09-30)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.